Here are the DEF 14A proxy statements from INNOVATE Corp. (VATE) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow VATE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VATE filings page.
INNOVATE Corp. is holding its 2026 annual stockholder meeting virtually on June 11, 2026, where common and preferred holders will vote together on four key proposals.
Stockholders will elect four directors, cast an advisory vote on executive pay, approve an increase in shares available under the Second Amended and Restated 2014 Omnibus Equity Award Plan, and ratify BDO USA, P.C. as auditor. The board recommends voting FOR all items.
The proxy also highlights 2025 business results, including DBM Global revenue of $1,210.3 million, up 12.9% year-over-year, MediBeacon kidney-function product approvals in the U.S. and China, and record revenue at R2 Technologies. Governance features include a separate independent chair and CEO, majority voting for uncontested director elections, performance-based compensation, and minimum one-year vesting on equity awards. In 2025 the interim CEO’s reported pay was $1.84 million and the CFO’s was $0.94 million, combining salary, equity and incentives aligned with company performance.